An Optimised GA Interventional Trial (Opti-GAIN) to Test if Treatment With CTx001 is Safe and Works for People With Geographic Atrophy (GA)
for Geographic Atrophy Secondary to Age-related Macular Degeneration
4 locations incl. Carmel
Sponsor: Complement Therapeutics
Sex: All·Age: 55+
Code: NCT07392255·Phase 1, Phase 2·Recruiting